Osteoarthritis Therapeutics Market Size, Share, Growth Analysis, By Anatomy (Knee Osteoarthritis, Hip Osteoarthritis), By Drug Type (Viscosupplementation Agents, Non-Steroidal Anti-inflammatory Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region -Industry Forecast 2025-2032

Global Osteoarthritis Therapeutics Market size was valued at USD 7.99 Billion in 2022 poised to grow from USD 8.54 Billion in 2023 to USD 14.56 Billion by 2031, growing at a CAGR of 6.89% in the forecast period (2024-2031).

Considering that osteoarthritis is increasingly among the common diseases especially in old people and lot of R&D is going in developing newer therapeutics for osteoarthritis; hence, the market is predicted to grow to huge new heights. More than 32.5 million Americans suffer from osteoarthritis according to CDC data on January 2023, which shows the growing need for efficacious therapies. Market expansion is anticipated to be further fuelled by ongoing developments in the understanding of diseases and the creation of treatment solutions. The main causes of women's increased risk include musculoskeletal abnormalities and hormonal changes related to menstruation and menopause.

Moreover, according to the National Institutes of Health, in the United States females are more likely to have obesity than males, which, in turn, predisposes them to osteoarthritis. Thus, the presence of such statistics highlights that osteoarthritis is one prevalent and costly condition disparately burdens women, causing the projections of market growth and the development of targeted solutions for the whole projected period. OA's thick and avascular tissue nature makes management extremely difficult. However, specific medication delivery systems have been developed because of the introduction of intra-articular (IA) drug administration. Research and development for new OA treatments is expected to be improved by the focus on disease-modifying medications and bioadaptive carriers.